New findings also show that the diabetes-induced metabolic milieu is specifically conducive to AD-P processes with greater β-amyloid plaque and tau deposition, advanced glycation end products and activated microglia in diabetic AD compared to non-diabetic AD (29, 30). Here, MAPT is linked to Alzheimer disease.